Leerink Partners Raises Price Target on Imprivata (IMPR) to $16 Following 1Q Beat and Raise
Tweet Send to a Friend
Leerink Partners reiterated an Outperform rating on Imprivata (NYSE: IMPR), and raised the price target to $16.00 (from $13.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
